Nuvation Bio (NUVB) Q3 2024 Earnings
NUVB·Reported November 6, 2024·Before market open
Nuvation Bio reported Q3 2024 revenue of $727.0K. Diluted EPS came in at $-0.15, missed the $-0.13 consensus by $0.02.
Revenue
$727.0K
Diluted EPS
$-0.15missed by $0.02
Consensus: $-0.13
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Nuvation Bio's Q3 2024 earnings report.
Nuvation Bio (NUVB) reported Q3 2024 earnings on November 6, 2024 before market open.
Nuvation Bio reported revenue of $727.0K and diluted EPS of $-0.15 for Q3 2024.
EPS missed the consensus estimate of $-0.13 by $0.02.
You can read the 10-Q periodic report (0000950170-24-122402) directly on SEC EDGAR. The filing index links above go to sec.gov.